Clinical Trial Detail

NCT ID NCT03168464
Title Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Weill Medical College of Cornell University
Indications

lung non-small cell carcinoma

Therapies

Nivolumab

Age Groups: adult senior

No variant requirements are available.